Abstract:CYP24A1 is a multifunctional, P450 mitochondrial 24-hydroxylase enzyme that is responsible for catabolism of the most active vitamin D hormone (calcitriol, 1,25(OH)2D3), its precursor (calcifediol, 25(OH)D3), and numerous other vitamin D metabolites at the 23- and 24-carbon positions. In the kidney, Cyp24a1 is induced by 1,25(OH)2D3, induced by FGF23, and potently suppressed by PTH to tightly control the circulating blood levels of 1,25(OH)2D3. This gene is believed to be under the control of a pair of classic promoter proximal (PRO) vitamin D response elements (VDREs) that are aided by distal, downstream (DS) containing enhancers that we identified more recently. The DS1 enhancer cluster was found to respond to PTH and FGF23 actions in a kidney-specific manner. The DS2 enhancer cluster was found to assist in the response of 1,25(OH)2D3 in kidney, as well as other target tissues. Despite this knowledge, the in vivo contribution of the PRO VDREs to gene expression, what drives Cyp24a1 basal expression in the kidney, how FGF23 activates Cyp24a1, and importantly, how PTH suppresses Cyp24a1, all remain unknown. Here in this study, we utilize homology directed CRISPR to mutate one or both VDREs in the PRO region of the Cyp24a1 gene in vivo in the mouse to address these questions. We found that the VDRE (VDRE1) more proximal to the to the transcriptional start site (TSS) is the dominant VDRE of the pair and mutation of both VDREs leads to a dramatic loss of VDR, a reduction of Cyp24a1 gene expression in the kidney, and a near elimination of 1,25(OH)2D3 induction in the intestine. FGF23 induction of Cyp24a1 was reduced with mutation of the PRO VDREs, however, co-treatment of 1,25(OH)2D3 and FGF23 synergistically increased Cyp24a1 expression even with the loss of the PRO VDREs. PTH suppression of Cyp24a1 gene expression was unchanged with PRO VDRE mutations, despite a minor reduction in total pCREB occupancy. Finally, VDR occupancy was dramatically reduced across the DS enhancers in the Cyp24a1 locus after the PRO VDREs mutation. Taken together, our data suggest a cooperative relationship between the DS and PRO enhancers in the regulation of Cyp24a1 by 1,25(OH)2D3 and FGF23, and despite the overall reduction of CREB on the genome it appeared that suppression either does not rely on CREB or that the PRO VDREs are unconnected to PTH suppression altogether. These studies point to the DS1 region as a basal switch for Cyp24a1 expression and help further define the interconnected genomic control of these hormones on vitamin D catabolism.

Substrate 1,25(OH)2D3 and Adrenodoxin Exert a Coordinated Change in CYP24A1 Structure

Deciphering Allosteric Coupling Between Substrate Binding and Redox Partner Recognition in Rat CYP24A1, a Vitamin‐D C‐24 Hydroxylase

Evidence of Allosteric Coupling Between Substrate Binding and Adx Recognition in the Vitamin D Carbon-24 Hydroxylase CYP24A1

The cytochrome P450 24A1 interaction with adrenodoxin relies on multiple recognition sites that vary among species

Interactions of human mitochondrial Ferredoxin 1 (Adrenodoxin) by NMR; modulation by cytochrome P450 substrate and by truncation of the C-terminal tail

Adrenodoxin allosterically alters human cytochrome P450 11B enzymes to accelerate substrate binding and decelerate release

Phosphorylation Of Bovine Adrenodoxin By Protein Kinase Ck2 Affects The Interaction With Its Redox Partner Cytochrome P450(Scc) (Cyp11a1)

Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity.

Substrate-induced modulation of protein-protein interactions within human mitochondrial cytochrome P450-dependent system

Structural dynamics of cytochrome P450 3A4 in the presence of substrates and cytochrome P450 reductase

Microsoft Word-31088317-file00

Substrate Binding Stabilizes<i>S</i>-Adenosylhomocysteine Hydrolase in a Closed Conformation<sup>†</sup>

In vivo contribution of promoter vitamin D response elements

In vivo contribution of Cyp24a1 promoter vitamin D response elements

In Vivo Evidence for A Novel Pathway of Vitamin D-3 Metabolism Initiated by P450scc and Modified by Cyp27b1

Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule

Molecular determinant of substrate binding and specificity of cytochrome P450 2J2

Catalysis-associated Conformational Changes Revealed by Human CD38 Complexed with a Non-Hydrolyzable Substrate Analog.

Functional Analysis of Human Cytochrome P 450 21 A 2 Variants Involved in Congenital Adrenal Hyperplasia

Defining CYP3A4 structural responses to substrate binding. Raman spectroscopic studies of a nanodisc-incorporated mammalian cytochrome P450.

The Crystal Structures Of 4-Methoxybenzoate Bound Cyp199a2 And Cyp199a4: Structural Changes On Substrate Binding And The Identification Of An Anion Binding Site